News for Lannett Company, Inc. - Google Finance

Lannett Co Inc Earnings: Here's Why Investors Like These Results

Wed, 08 May 2013 21:48:46 GMT

Lannett Co Inc Earnings: Here's Why Investors Like These Results
Wall St. Cheat Sheet - May 8, 2013

Lannett Co Inc (AMEX:LCI) delivered a profit and beat Wall Street's expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company.

Needham & Company Starts Lannett Co (LCI) at Buy

Thu, 23 May 2013 11:51:55 GMT

Needham & Company Starts Lannett Co (LCI) at Buy
StreetInsider.com (subscription) - May 23, 2013

Inc., a fully-integrated pharmaceutical company with broad manufacturing expertise and a vertically-integrated pain management franchise, with a Buy rating and $15 PT.

LANNETT COMPANY, INC. : Lannett Announces Preliminary Fiscal 2013 Third ...

Tue, 30 Apr 2013 20:13:24 GMT

LANNETT COMPANY, INC. : Lannett Announces Preliminary Fiscal 2013 Third ...
4-traders (press release) - Apr 30, 2013

Lannett Company, Inc. (NYSE MKT: LCI) today announced that it expects to report fiscal 2013 third quarter net sales of approximately $39 million and diluted earnings per share between $0.12 and $0.14.

Lannett Announces Preliminary Fiscal 2013 Third Quarter Net Sales of $39 ... - MarketWatch (press release)

Lannett Co Now Covered by Needham & Company (LCI)

Thu, 23 May 2013 21:17:14 GMT

Lannett Co Now Covered by Needham & Company (LCI)
Zolmax - May 23, 2013

Analysts at Canaccord Genuity raised their price target on shares of Lannett Co from $10.00 to $13.00 in a research note to investors on Thursday, May 2nd.

Lannett Company Incorporated Receives New Coverage from Analysts at ...

Thu, 23 May 2013 12:19:15 GMT

Lannett Company Incorporated Receives New Coverage from Analysts at ...
Daily Political - May 23, 2013

The company's quarterly revenue was up 27.0% on a year-over-year basis. Analysts expect that Lannett Company Incorporated will post $0.43 EPS for the current fiscal year.

Lannett Company Incorporated Rating Increased to Outperform at Zacks (LCI)

Wed, 08 May 2013 19:22:24 GMT

Lannett Company Incorporated Rating Increased to Outperform at Zacks (LCI)
Zolmax - May 8, 2013

Separately, analysts at Oppenheimer raised their price target on shares of Lannett Company Incorporated from $6.00 to $9.00 in a research note to investors on Friday, February 8th.

Lannett Company Incorporated (LCI) Posts Quarterly Earnings, Beats ... - The Utah People's Post

Lannett Co PT Raised to $12.75 at Roth Capital (LCI)

Mon, 13 May 2013 15:38:47 GMT

Lannett Co PT Raised to $12.75 at Roth Capital (LCI)
Zolmax - May 13, 2013

Lannett Company, Inc. is engaged in developing, manufacturing, marketing and distributing generic versions of branded pharmaceutical products.

Lannett Company Incorporated Upgraded by Zacks to "Outperform" (LCI)

Fri, 10 May 2013 15:16:11 GMT

Lannett Company Incorporated Upgraded by Zacks to "Outperform" (LCI)
Daily Political - May 10, 2013

Finally, Zacks reiterated its neutral rating on shares of Teva Pharmaceutical Industries Ltd. They have a $40.00 price target on that stock.

Lannett Co PT Raised to $13.00 (LCI)

Thu, 02 May 2013 21:25:07 GMT

Lannett Co PT Raised to $13.00 (LCI)
Daily Political - May 2, 2013

Lannett Co Inc logo Canaccord Genuity raised their price target on shares of Lannett Co (AMEX: LCI) from $10.00 to $13.00 in a research note issued on Thursday, ARN reports.

Lannett Co PT Raised to $12.75 (LCI)

Thu, 09 May 2013 22:50:38 GMT

Lannett Co PT Raised to $12.75 (LCI)
The Utah People's Post - May 9, 2013

Lannett Co Inc logo Analysts at Roth Capital increased their price target on shares of Lannett Co (AMEX: LCI) from $12.00 to $12.75 in a research report issued to clients and investors on Thursday, StockRatingsNetwork reports.